HOME >> MEDICINE >> NEWS
Large tularemia vaccine contracts among new NIAID biodefense awards

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced that it has recently made several dozen awards to further strengthen the nation's biodefense and emerging disease research capabilities. The new awards include grants totaling approximately $87 million for the construction of four biosafety level-3 (BSL-3) laboratories as well as two five-year contracts totaling approximately $60 million to support the development of a vaccine against tularemia, a potential agent of bioterror.

"Devising medical countermeasures against biological threats, whether they arise naturally or are the result of deliberate human action, is a top priority for NIAID," says NIAID Director Anthony S. Fauci, M.D. "These new awards support research needed to better understand and defend against disease-causing microbes and provide funds to construct facilities where such research can be performed safely."

Regional Biocontainment Laboratories

The four new labs will join nine other NIAID-funded BSL-3 labs in the Institute's Regional Biocontainment Laboratory (RBL) program. In 2002, a panel of experts convened to provide guidance to NIAID on its biodefense agenda cited insufficient BSL-3 and BSL-4 space as a major barrier to research progress. As part of its response, NIAID established the RBL program to fund the design, construction and commissioning of state-of-the-art BSL-3 labs at sites spanning the country. The institutions receiving the new awards and the principal investigators are as follows:

  • Charles Bailey, Ph.D., George Mason University, Manassas, VA
  • Sawkat Anwer, D.M.V.H., Ph.D., Tufts University, North Grafton, MA
  • Nancy Martin, Ph.D., University of Louisville, KY
  • James Gaines, Ph.D., University of Hawaii at Manoa

More information about NIAID's biocontainment facility construction program and a map of the previously awarded sites is at <
'"/>

Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
3-Oct-2005


Page: 1 2 3

Related medicine news :

1. Largest ever grant for University of Copenhagenhagen
2. Large subset of learning disabled children can be quickly identified by new diagnostic device
3. Large collaborative effort provides first publicly available genetic data for Parkinsons research
4. Largest review of Loeys-Dietz Syndrome to date
5. Large-scale cross-platform study of research microarrays uncovers high concordance across platforms
6. Large NCI grant will test the effect of Tibetan yoga on women with breast cancer
7. Large prospective study examines colon cancer risk in women
8. Large study shows low-fat diet has little effect on reducing risk of breast cancer
9. Largest study of in-hospital cardiac arrest suggests how to improve outcomes for children and adults
10. Large-scale study proves volunteer operated defibrillators are life-savers
11. Largest survey on depression suggests higher prevalence in U.S., reports Mailman school

Post Your Comments:
(Date:7/29/2015)... ... , ... A June 10, 2015 article from the News-Press, entitled " It's ... having regular skin cancer screenings from an early age. Skin cancer can strike at ... early, skin cancer is rarely fatal; however, if left alone for too long, the ...
(Date:7/29/2015)... ... July 29, 2015 , ... Employee Fiduciary, LLC announces the launch of ... information, website, types of plans administered, years in business, and credentials of all Employee ... least one plan with Employee Fiduciary. A search can be done by zip code ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Several years ... population of children with autism, Little City took a proactive stance and began planning ... The Coleman Foundation grant provides valuable support to building the third home. , “We ...
(Date:7/29/2015)... ... July 29, 2015 , ... Attorneys representing American families in ... Lawsuit Center. The website now features a page dedicated to news related to pending ... sources. The Talcum Powder Lawsuit News page was launched with eight initial ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... thinker.” Since the late 1970s, Dr. Cottrell has been making predictions about the ... New Earth, documents many of these prognostications. He warns that extreme weather conditions ...
Breaking Medicine News(10 mins):Health News:Get Checked for Skin Cancer Early and Often 2Health News:Get Checked for Skin Cancer Early and Often 3Health News:Employee Fiduciary Launches Financial Advisor Directory 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 2Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 3Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2
(Date:7/29/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/hmjqff/global_wound_care ... "Global Wound Care Markets (Twelve Country Analysis: Germany, ... China, India, Brazil, Australia, South Korea)" report ... provides a competitive market summary. The wound care ... offerings and product maturity. Several of the products ...
(Date:7/29/2015)... BURLINGTON, Mass. , July 29, 2015   ... device market in Europe will ... unfavorable economic conditions across the Eurozone. On a longer ... the elderly, obese, and physically active will increase the ... treatment via arthroscopy devices and orthopedic soft tissue solutions. ...
(Date:7/29/2015)... Juli 2015 In der klinischen ... die tägliche Einnahme des L. reuteri ... anreichert und die Darmproduktion von Proteinfaktoren verändert, ... die tägliche Einnahme von Nutraceutix, L. ... Verwendung der patentierten Verabreichungstechnologie BIO- tract ®, ...
Breaking Medicine Technology:Global Wound Care Markets 2015 2The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023 2The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023 3Klinischer Nachweis erbracht, dass L. reuteri Probiotikum von Nutraceutix den Darm-Insulinmetabolismus moduliert 2
Cached News: